XL092 (STELLAR-001)
A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors (STELLAR-001)
Condition: Colorectal | Last Updated: 3 Jun 22 | Status:
View Full Study
COVID-19: We are currently offering vaccinations to current qualifying patients. CURRENT PATIENTS VACCINATION INFO.
Cancer Treatment Team
Meet Our Team
Learn more about our Cancer Treatment Team by scrolling below, or visit our Meet the Team page.
